美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPDR S&P International Industria

34.71

0.0000

成交量：- -

成交額：- -

市值：2,082.60萬

市盈率：3.89

高：34.71

開：34.71

低：34.71

收：34.71

52周最高：34.71

52周最低：34.71

股本：60.00萬

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):8.93

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

益普生2025年業績強勁增長，三大治療領域穩紮穩打，並發布2026年全年指引

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/IPN"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IPN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPN\",,,,,undefined,":{"symbol":"IPN","market":"US","secType":"STK","nameCN":"SPDR S&P International Industria","latestPrice":34.71,"timestamp":1787688000000,"preClose":34.71,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":600000,"eps":8.9298,"marketStatus":"盤前交易","change":0,"latestTime":"08-26 06:31:24 EDT","open":34.71,"high":34.71,"low":34.71,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.9298,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":34.71,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPN\",,,,,undefined,":{"symbol":"IPN","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":600000,"dividePrice":0,"high":34.71,"amplitude":0,"preClose":34.71,"low":34.71,"week52Low":34.71,"pbRate":"--","week52High":34.71,"institutionHeld":0,"latestPrice":34.71,"eps":8.9298,"divideRate":0,"volume":0,"delay":0,"ttmEps":8.9298,"open":34.71,"prevYearClose":34.71,"prevWeekClose":34.71,"prevMonthClose":34.71,"prevQuarterClose":34.71,"fiveDayClose":34.71,"twentyDayClose":34.71,"sixtyDayClose":34.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-06-16","symbol":"IPN","amount":0.357922,"name":"SPDR S&P International Industria","recordDate":"2017-06-28","payableDate":"2017-06-20","currency":"USD","type":"dividend","dateTimestamp":1497585600000},{"market":"US","date":"2017-03-17","symbol":"IPN","amount":0.016732,"name":"SPDR S&P International Industria","recordDate":"2017-03-29","payableDate":"2017-03-21","currency":"USD","type":"dividend","dateTimestamp":1489723200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPN\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-29","value":0.016732,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-28","value":0.357922,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPN\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611077151","title":"益普生2025年業績強勁增長，三大治療領域穩紮穩打，並發布2026年全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2611077151","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611077151?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 19:49","pubTimestamp":1770983340,"startTime":"0","endTime":"0","summary":"\" 2026年全年指引及中期展望 益普生为2026财年制定了以下财务指引：  以固定汇率计算，总销售额增长超过13.0%。研发管线进展 2025年，益普生在不同产品组合实现多项重要的监管和临床里程碑，反映了三个治疗领域的研发管线持续推进。2025年9月，益普生公布了IPN10200在医美领域LANTIC Ⅱ期临床的积极数据，显示该产品具有差异化的长效临床特征。外部创新 2025年12月，益普生通过收购ImCheck Therapeutics进一步扩展了肿瘤免疫治疗产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/4887760_ZH87760_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4887760_ZH87760_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4159","BK4139","BOLD","CAGR","IPSEF","EMA","BK4081","IPN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IPN\",params:#limit:6,delay:false,,,undefined,":[]}}